Liang 2020.
Study characteristics | |||
Patient Sampling | Based on epidemiological history, clinical and radiological manifestations, cases with possible or probable COVID‐19 were sent for panel discussion. Paediatric patients were not included. | ||
Patient characteristics and setting | Setting: fever clinic, pre‐screened
Site: Peking University Third Hospital from 21 January‐15 February 2020
Country: China
Symptoms and severity: on presentation, most patients (85.7%) had fever with a mean body temperature of 37.8. Cough (42.9%), expectoration (33.3%), fatigue (57.1%), headache or dizziness (38.1%) were common symptoms. Other symptoms included shortness of breath, myalgia or arthralgia, sore throat, nasal symptoms and diarrhoea.
Demographics: male/female Age: 24‐85 years (median 42.0, range 34.5‐66) Exposure history: imported cases from Wuhan City or Hubei Province 6 (28.6%); known contact with individuals from Wuhan or Hubei 1 (4.8%); known contact with cases of confirmed COVID‐19 5 (23.8%); family aggregation onset 7 (33.3%) Time since onset of symptoms: between 2 and 10 days |
||
Index tests | Not much information reported. For all index tests, see Table 4 |
||
Target condition and reference standard(s) | RT‐PCR. Laboratory testing of 2019‐nCoV in throat swabs was performed by both Beijing Centers for Disease Control and Prevention (CDC) and Haidian District CDC. 2019‐nCoV infection was target condition | ||
Flow and timing | |||
Comparative | |||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | No | ||
If a threshold was used, was it pre‐specified? | Unclear | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | No | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | High risk |